# Contineum Therapeutics, Inc.: Form 8-K/A, filed Aug 14, 2024

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: 8-K/A
- Filed: 2024-08-14
- Accepted by EDGAR: Aug 14, 2024, 12:19 ET
- Period: 2024-08-13
- Accession: 0001437749-24-026664
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000143774924026664/cont20240813_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000143774924026664/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000143774924026664/cont20240813_8ka.htm

Filed Aug 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-026664. Last ingested by Listed: Nov 6, 2026, 12:53 ET. No prices; not investment advice.